GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals

Human GIP(3-30)NH 2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors

(2018) Maria Buur Nordskov Gabe et al.   BIOCHEMICAL PHARMACOLOGY

Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer

(2018) Andreas Brønden et al.   DIABETES OBESITY & METABOLISM

Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity

(2018) Christina C. Nexøe-Larsen et al.   DIABETES OBESITY & METABOLISM

Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas

(2018) Rune E. Kuhre et al.   Molecular Metabolism

Effects of meal and incretins in the regulation of splanchnic blood flow

(2017) Jukka Koffert et al.   Endocrine Connections

Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery

(2016) Maria S. Svane et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Insulinotropic Effects of Whey: Mechanisms of Action, Recent Clinical Trials, and Clinical Applications

(2016) Rachel L. Adams et al.   ANNALS OF NUTRITION AND METABOLISM

The biology of glucagon and the consequences of hyperglucagonemia

(2016) Nicolai J Wewer Albrechtsen et al.   Biomarkers in Medicine

N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor

(2016) L S Hansen et al.   BRITISH JOURNAL OF PHARMACOLOGY

Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist

(2016) Michael A. Nauck et al.   DIABETES

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

(2016) Ulrich Rohde et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Acute load-dependent effects of oral whey protein on gastric emptying, gut hormone release, glycemia, appetite, and energy intake in healthy men

(2015) Amy T Hutchison et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Incretin Effect After Oral Amino Acid Ingestion in Humans

(2015) Ola Lindgren et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men

(2014) Robert E Steinert et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes

(2014) Mikkel Christensen et al.   DIABETES

GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

(2014) L. van Bloemendaal et al.   DIABETES

Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1

(2014) David P Sonne et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Glucose-Dependent Insulinotropic Polypeptide Inhibits Bone Resorption in Humans

(2014) Anne Nissen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes

(2013) Nils B. Jørgensen et al.   DIABETES

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass

(2013) C Dirksen et al.   INTERNATIONAL JOURNAL OF OBESITY

Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes

(2013) Mikkel B. Christensen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes

(2012) Elza Muscelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion

(2011) HE Parker et al.   BRITISH JOURNAL OF PHARMACOLOGY

Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans

(2011) M. Christensen et al.   DIABETES

Incretin Hormone and Insulin Responses to OralVersusIntravenous Lipid Administration in Humans

(2011) Ola Lindgren et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes

(2011) Jonatan I. Bagger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Endogenous GLP-1 Regulates Postprandial Glycemia in Humans: Relative Contributions of Insulin, Glucagon, and Gastric Emptying

(2010) Mathias Nicolaus et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia

(2009) Adam M. Deane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Regulation of Islet Hormone Release and Gastric Emptying by Endogenous Glucagon-Like Peptide 1 after Glucose Ingestion

(2008) Marzieh Salehi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM